GENTAUR Molecular Products.
Monoclonal Antibody, ELISA Kit, Polyclonal Antibody, Recombinant/Purified Protein.Did you know ? If you order before Friday 14h we deliver 90PCT of the the time next Tuesday, GENTAUR another in time delivery
Toxin PAU_02230 (Photorhabdus asymbiotica toxin) (PaTox) [Includes: Protein N-acetylglucosaminyltransferase (Protein O-GlcNAc transferase) (EC 2.4.1.-) (PaToxG) (Tyrosine glycosyltransferase); Protein-glutamine amidohydrolase (EC 3.5.1.44) (Glutamine deamidase) (PaToxD) (Protein-glutamine glutaminase)]
PATOX_PHOAA Reviewed; 2957 AA.
C7BKP9;
11-NOV-2015, integrated into UniProtKB/Swiss-Prot.
22-SEP-2009, sequence version 1.
13-FEB-2019, entry version 43.
RecName: Full=Toxin PAU_02230 {ECO:0000305};
AltName: Full=Photorhabdus asymbiotica toxin {ECO:0000303|PubMed:24141704};
Short=PaTox {ECO:0000303|PubMed:24141704};
Includes:
RecName: Full=Protein N-acetylglucosaminyltransferase {ECO:0000305|PubMed:24141704};
Short=Protein O-GlcNAc transferase {ECO:0000305|PubMed:24141704};
EC=2.4.1.- {ECO:0000269|PubMed:24141704};
AltName: Full=PaToxG {ECO:0000303|PubMed:24141704};
AltName: Full=Tyrosine glycosyltransferase {ECO:0000303|PubMed:24141704};
Includes:
RecName: Full=Protein-glutamine amidohydrolase {ECO:0000305|PubMed:24141704};
EC=3.5.1.44 {ECO:0000269|PubMed:24141704};
AltName: Full=Glutamine deamidase {ECO:0000303|PubMed:24141704};
AltName: Full=PaToxD {ECO:0000303|PubMed:24141704};
AltName: Full=Protein-glutamine glutaminase {ECO:0000305};
OrderedLocusNames=PAU_02230 {ECO:0000312|EMBL:CAQ84322.1};
Photorhabdus asymbiotica subsp. asymbiotica (strain ATCC 43949 /
3105-77) (Xenorhabdus luminescens (strain 2)).
Bacteria; Proteobacteria; Gammaproteobacteria; Enterobacterales;
Morganellaceae; Photorhabdus.
NCBI_TaxID=553480 {ECO:0000312|Proteomes:UP000002747};
[1]
NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
STRAIN=ATCC 43949 / 3105-77;
PubMed=19583835; DOI=10.1186/1471-2164-10-302;
Wilkinson P., Waterfield N.R., Crossman L., Corton C.,
Sanchez-Contreras M., Vlisidou I., Barron A., Bignell A., Clark L.,
Ormond D., Mayho M., Bason N., Smith F., Simmonds M., Churcher C.,
Harris D., Thompson N.R., Quail M., Parkhill J.,
ffrench-Constant R.H.;
"Comparative genomics of the emerging human pathogen Photorhabdus
asymbiotica with the insect pathogen Photorhabdus luminescens.";
BMC Genomics 10:302-302(2009).
[2]
SUBCELLULAR LOCATION, AND MUTAGENESIS OF 2134-ARG-LYS-2135 AND
2139-ARG-LYS-2140.
STRAIN=ATCC 43950;
PubMed=25782990; DOI=10.1096/fj.14-269381;
Jank T., Trillhaase C., Brozda N., Steinemann M., Schwan C., Suess R.,
Aktories K.;
"Intracellular plasma membrane guidance of Photorhabdus asymbiotica
toxin is crucial for cell toxicity.";
FASEB J. 29:2789-2802(2015).
[3]
X-RAY CRYSTALLOGRAPHY (1.80 ANGSTROMS) OF 2114-2449 IN COMPLEX WITH
CALCIUM AND UDP-GLCNAC, FUNCTION, CATALYTIC ACTIVITY, COFACTOR,
SUBSTRATE SPECIFICITY, DOMAIN, AND MUTAGENESIS OF TRP-2170; ASP-2260;
ARG-2263; ASP-2276; ASP-2278; ASP-2279; 2276-ASP--ASP-2279; ASN-2312
AND CYS-2509.
STRAIN=ATCC 43950;
PubMed=24141704; DOI=10.1038/nsmb.2688;
Jank T., Bogdanovic X., Wirth C., Haaf E., Spoerner M., Boehmer K.E.,
Steinemann M., Orth J.H., Kalbitzer H.R., Warscheid B., Hunte C.,
Aktories K.;
"A bacterial toxin catalyzing tyrosine glycosylation of Rho and
deamidation of Gq and Gi proteins.";
Nat. Struct. Mol. Biol. 20:1273-1280(2013).
-!- FUNCTION: Toxin that acts on host cells by modifying Rho proteins
by tyrosine GlcNAcylation and heterotrimeric G alpha proteins by
deamidation. Catalyzes the mono-O-GlcNAcylation of small GTPases
of the Rho family (RhoA, RhoB, RhoC, Rac1, Rac2, Rac3, Cdc42) in
eukaryotic host cells at the conserved tyrosine residue located in
the switch I region (Tyr-32/34), using UDP-N-acetylglucosamine
(UDP-GlcNAc) as the sugar donor; other GTPases of the Rho, Ras or
Rab families are not substrates. Tyrosine glycosylation inhibits
Rho activation and prevents interaction with downstream effectors,
resulting in actin disassembly, inhibition of phagocytosis, cell
rounding, and toxicity toward insects and mammalian cells. Also
catalyzes the deamidation of the catalytic glutamine in
heterotrimeric G alpha proteins (Gi, Gq/11), which blocks GTP
hydrolysis and arrests the G proteins in a permanent active state
leading to activation of Rho GTPases. Thus, PaTox hijacks host
GTPase signaling in a bidirectional manner by deamidation-induced
activation and glycosylation-induced inactivation of GTPases.
{ECO:0000269|PubMed:24141704}.
-!- CATALYTIC ACTIVITY:
Reaction=L-tyrosyl-[protein] + UDP-N-acetyl-alpha-D-glucosamine =
H(+) + O-(N-acetyl-alpha-D-glucosaminyl)-L-tyrosyl-[protein] +
UDP; Xref=Rhea:RHEA:51536, Rhea:RHEA-COMP:10136, Rhea:RHEA-
COMP:13016, ChEBI:CHEBI:15378, ChEBI:CHEBI:46858,
ChEBI:CHEBI:57705, ChEBI:CHEBI:58223, ChEBI:CHEBI:134208;
Evidence={ECO:0000269|PubMed:24141704};
-!- CATALYTIC ACTIVITY:
Reaction=H2O + L-glutaminyl-[protein] = L-glutamyl-[protein] +
NH4(+); Xref=Rhea:RHEA:16441, Rhea:RHEA-COMP:10207, Rhea:RHEA-
COMP:10208, ChEBI:CHEBI:15377, ChEBI:CHEBI:28938,
ChEBI:CHEBI:29973, ChEBI:CHEBI:30011; EC=3.5.1.44;
Evidence={ECO:0000269|PubMed:24141704};
-!- COFACTOR:
Name=a divalent metal cation; Xref=ChEBI:CHEBI:60240;
Evidence={ECO:0000269|PubMed:24141704};
Note=A Ca(2+) ion is seen in the structure.
{ECO:0000269|PubMed:24141704};
-!- SUBCELLULAR LOCATION: Secreted {ECO:0000305}. Host cell membrane
{ECO:0000269|PubMed:25782990}; Peripheral membrane protein
{ECO:0000269|PubMed:25782990}; Cytoplasmic side
{ECO:0000269|PubMed:25782990}. Note=Associates with the negatively
charged inner leaflet of the plasma membrane via interaction with
phosphatidylserine and phosphatidylinositolphosphates. Plasma
membrane localization of PaTox is essential for cytotoxicity. The
glycosyltransferase domain alone is sufficient to localize at the
plasma membrane. {ECO:0000269|PubMed:25782990}.
-!- DOMAIN: In the C-terminal region, contains two catalytic domains:
a glycosyltransferase (PaToxG) and a deamidase domain (PaToxD).
The N-terminal region contains a receptor-translocation domain
necessary for toxin entry into the cytoplasm of host cell.
{ECO:0000269|PubMed:24141704}.
-!- MISCELLANEOUS: The active GTP-bound conformation of Rho is the
preferred substrate for PaTox-induced glycosylation.
{ECO:0000269|PubMed:24141704}.
-----------------------------------------------------------------------
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
-----------------------------------------------------------------------
EMBL; FM162591; CAQ84322.1; -; Genomic_DNA.
PDB; 4MIX; X-ray; 1.80 A; A/B=2114-2449.
PDB; 6HV6; X-ray; 2.00 A; A=1701-2114.
PDBsum; 4MIX; -.
PDBsum; 6HV6; -.
SMR; C7BKP9; -.
STRING; 553480.PAU_02230; -.
PRIDE; C7BKP9; -.
EnsemblBacteria; CAQ84322; CAQ84322; PAU_02230.
KEGG; pay:PAU_02230; -.
eggNOG; ENOG4106EE1; Bacteria.
eggNOG; ENOG410Y12W; LUCA.
Proteomes; UP000002747; Chromosome.
GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
GO; GO:0020002; C:host cell plasma membrane; IEA:UniProtKB-SubCell.
GO; GO:0016020; C:membrane; IEA:UniProtKB-KW.
GO; GO:0005509; F:calcium ion binding; IDA:UniProtKB.
GO; GO:0016262; F:protein N-acetylglucosaminyltransferase activity; IDA:UniProtKB.
GO; GO:0050568; F:protein-glutamine glutaminase activity; IDA:UniProtKB.
GO; GO:0090729; F:toxin activity; IEA:UniProtKB-KW.
GO; GO:0036210; P:protein modification process in other organism; IDA:UniProtKB.
GO; GO:0043087; P:regulation of GTPase activity; IDA:UniProtKB.
InterPro; IPR007577; GlycoTrfase_DXD_sugar-bd_CS.
InterPro; IPR029044; Nucleotide-diphossugar_trans.
InterPro; IPR028907; Tox-PLDMTX_dom.
Pfam; PF04488; Gly_transf_sug; 1.
Pfam; PF15645; Tox-PLDMTX; 1.
SUPFAM; SSF53448; SSF53448; 1.
1: Evidence at protein level;
3D-structure; Calcium; Complete proteome; Glycosyltransferase;
Host cell membrane; Host membrane; Hydrolase; Membrane; Metal-binding;
Multifunctional enzyme; Reference proteome; Secreted; Toxin;
Transferase; Virulence.
CHAIN 1 2957 Toxin PAU_02230.
/FTId=PRO_0000434568.
REGION 2115 2449 Tyrosine glycosyltransferase PaToxG.
{ECO:0000305|PubMed:24141704}.
REGION 2115 2144 Membrane localization domain that
interacts with the inner leaflet of the
plasma membrane.
{ECO:0000269|PubMed:25782990}.
REGION 2169 2171 UDP-GlcNAc binding.
{ECO:0000269|PubMed:24141704}.
REGION 2259 2260 UDP-GlcNAc binding.
{ECO:0000269|PubMed:24141704}.
REGION 2450 2672 SseI-like deamidase PaToxD.
{ECO:0000305|PubMed:24141704}.
MOTIF 2276 2279 DxDD motif.
{ECO:0000305|PubMed:24141704}.
ACT_SITE 2509 2509 For deamidase activity.
{ECO:0000305|PubMed:24141704}.
ACT_SITE 2547 2547 For deamidase activity.
{ECO:0000305|PubMed:24141704}.
ACT_SITE 2562 2562 For deamidase activity.
{ECO:0000305|PubMed:24141704}.
METAL 2276 2276 Divalent metal cation.
{ECO:0000244|PDB:4MIX,
ECO:0000305|PubMed:24141704}.
METAL 2278 2278 Divalent metal cation.
{ECO:0000244|PDB:4MIX,
ECO:0000305|PubMed:24141704}.
BINDING 2312 2312 UDP-GlcNAc.
{ECO:0000269|PubMed:24141704}.
MUTAGEN 2134 2135 RK->EE: Abrogates plasma membrane
localization, resulting in a cytosolic
distribution of this mutant protein. Loss
of toxic activity on host cells during
the first hours of incubation. No effect
on glycosyltransferase activity and
interaction with RhoA.
{ECO:0000269|PubMed:25782990}.
MUTAGEN 2139 2140 RK->EE: Abrogates plasma membrane
localization, resulting in a cytosolic
distribution of this mutant protein. Loss
of toxic activity on host cells during
the first hours of incubation. No effect
on glycosyltransferase activity and
interaction with RhoA.
{ECO:0000269|PubMed:25782990}.
MUTAGEN 2170 2170 W->A: 7-fold reduction in
glycosyltransferase activity.
{ECO:0000269|PubMed:24141704}.
MUTAGEN 2260 2260 D->A: 10000-fold reduction in
glycosyltransferase activity. Reduced
cell toxicity.
{ECO:0000269|PubMed:24141704}.
MUTAGEN 2263 2263 R->A: 2000-fold reduction in
glycosyltransferase activity. Reduced
cell toxicity.
{ECO:0000269|PubMed:24141704}.
MUTAGEN 2276 2278 DID->NIN: Loss of glycosyltransferase
activity. Reduced toxicity in insect
larvae. Loss of the ability to block
phagocytosis in mammalian macrophages.
Loss of effect on actin skeleton.
{ECO:0000269|PubMed:24141704}.
MUTAGEN 2276 2276 D->N: 16700-fold reduction in
glycosyltransferase activity.
{ECO:0000269|PubMed:24141704}.
MUTAGEN 2278 2278 D->N: 333-fold reduction in
glycosyltransferase activity.
{ECO:0000269|PubMed:24141704}.
MUTAGEN 2279 2279 D->N: 700-fold reduction in
glycosyltransferase activity.
{ECO:0000269|PubMed:24141704}.
MUTAGEN 2312 2312 N->A: 1.3-fold reduction in
glycosyltransferase activity.
{ECO:0000269|PubMed:24141704}.
MUTAGEN 2509 2509 C->S: Loss of deamidase activity.
{ECO:0000269|PubMed:24141704}.
HELIX 2132 2153 {ECO:0000244|PDB:4MIX}.
STRAND 2164 2169 {ECO:0000244|PDB:4MIX}.
STRAND 2172 2174 {ECO:0000244|PDB:4MIX}.
HELIX 2178 2189 {ECO:0000244|PDB:4MIX}.
STRAND 2194 2200 {ECO:0000244|PDB:4MIX}.
HELIX 2208 2218 {ECO:0000244|PDB:4MIX}.
STRAND 2221 2227 {ECO:0000244|PDB:4MIX}.
HELIX 2228 2230 {ECO:0000244|PDB:4MIX}.
HELIX 2234 2239 {ECO:0000244|PDB:4MIX}.
HELIX 2241 2251 {ECO:0000244|PDB:4MIX}.
HELIX 2255 2270 {ECO:0000244|PDB:4MIX}.
STRAND 2272 2274 {ECO:0000244|PDB:4MIX}.
HELIX 2291 2293 {ECO:0000244|PDB:4MIX}.
STRAND 2312 2317 {ECO:0000244|PDB:4MIX}.
HELIX 2322 2337 {ECO:0000244|PDB:4MIX}.
HELIX 2343 2346 {ECO:0000244|PDB:4MIX}.
HELIX 2348 2358 {ECO:0000244|PDB:4MIX}.
HELIX 2360 2362 {ECO:0000244|PDB:4MIX}.
HELIX 2364 2382 {ECO:0000244|PDB:4MIX}.
HELIX 2399 2412 {ECO:0000244|PDB:4MIX}.
TURN 2413 2417 {ECO:0000244|PDB:4MIX}.
STRAND 2418 2420 {ECO:0000244|PDB:4MIX}.
SEQUENCE 2957 AA; 334884 MW; AE0C52A8C11E4C6B CRC64;
MKGIEGVIML SHDILPEKLL VSEKKHENVG SYFSDDIGEQ SEQTEVSHFN LSLDDAFDIY
ADISIENQQE LKNKDNNTNI WSSLGRGDDD HNLKKIINDA FKEKLPQLME YRRKGYNVIG
LDKEGIKKLE GMLKAVPPEI QQPTMKNLYS AAQELLNTLK QHPLLPENQD MIQQSNLVIR
NLSDALEAIN AVSKVNQVEW WEEVHKTNKA QSDRLIAATL EELFFKVKDK RLPGSNDDYC
QQEREETERK IKDLLLYDGY QLTAEHFKFG RLRKSLLAES RVTRLKLAEY LEKKSVGILT
AARDAKMYAM KILLAQTRNN GFNAKDLINA GQVNDRLLSF QQYARHIRAV DGEIDGIILS
NPLVVACIKE TNDEPAHIKI ARAILPVSEE LGTVSKVLRE TKEKVQPSKP KEELNHPHQD
WWNRGDELWK YIKKTSWNIK ETSVHVTQMV GYEASKTASR AKHKLKESSY SESINGAVKG
TALLLLDEIQ QAENRIRQIP QFAWDVQEAV EQHSSVIQRT AYPDELPELS ELLNEQLKHE
EARWQAVKKQ SRDKLQELIA PITRLAQEKW AQDLYFQLGE ELRKERQDRW KDIQQFDEIM
AEAVGQFAEM ARELDSEAVR LAEHGHSGGK ELQEKVAKWL RDLSKLKGKV KAGVAKITGT
SLDNFSRSGM LARGMSEWAE DLKQSYLQET LQEGSAVAAE LFERTLMEVV EENRTHFAKE
SDPEAERFLK RLALALKHAA ENTTVYPPTP EEILAGSRSL PEDIRHWAEK KVVSGAISAA
FRGGFKLVTG TFSLPVRVVI RGAKTGGTLY RGVRAINRSV RLGQGPATQV KSKFINQELS
KTAFRLTLSL SPLVAWGMAA SITAGRLYNE KDYPEKIIKN IVIDLPEELL WIGGYAGINA
AIRAHAEKAI QQAIQHALDE QADKLALRIN KEIAGKSADV NVEIIPQETS VSPAETAQST
PEPLSDFAST SQLTMPELID IQDNNSAQQP KVRRKRDVSV ESEISIDNLN IINANTREDK
VNSEIKSELR SELKRFENSD ANSPMSDVER AIFIDLFLYK NKYEVSESQQ DYKNTWLKFR
RELESQENKE IKEYLRFRSI IEAYEIYDKK RLDDDTIPEA GTIIKEVIDF FQKLKKENPI
TFMKLAEAMV KFQYYYEEED ENEDRYFKMA EIYYFLNKTE NEKKSKTFHL DIIDKYPNEN
NRLLDEFFLN KNNNNPDLDE IIYKLQSMQE KYRESYEMLS KVENIHQVLS DDSKNEENIF
LDNRIIAAQV FDGSINISLQ DKKKWLNRYD QIRNEEGSDG WKLMHIESIL INLRRINTAI
NLTAMKSESA LLLIDKLLNF QKKARENILH ISETPHEDFT SYSQFKTRKE LGNDDSKYYA
QFDNYKDNHD AEKEAKEILS QVVARASLSF SELFDKVESI KLFSFVYKNR DGGAPLAAPG
RTVVIKFPGK DTGGLVISNL FLRNHVKRIS TKEMEDLKPL TEGMYTRATQ HRSLGSYYHI
GSQSEHTNAL EILSGMNKEE LKTHLKKQGI WFGEPALFSN EYPKQENTGH LENTTLKNAI
IGVSTIQNNA AANYLRSTMY ESTGWEKLGD RFIPFYEIGR RKHYDREYEI NSEQLTLDII
TSIAIAYPAA RGIVATIRSS AIPSILKSGL RGSALFKSLS LELGKMGFNA SKVFGGAVYE
LIEPYPINSH LNRHNVFNKV KDTAWEFHTD VGLKGGGLKD FIDRFTKEPK EITISGYKFK
RIKYNQENFD TMQRMALDYA YNPDSKGKIA QAQQAYKTGK EDYNAPQYDN FNGLSLDKKI
ERYISPDTDA TTKGVLAGKM NESIKDINAF QTAKDAQSWK KSANKANKVV LTPQNLYLKG
KPSECLPESV LMGWALQSSQ DAKLSKMLMG IYSSNDITSN PLYKSLKELH ANGNASKFNA
SATSISNINV SNLATSETKL FPTEISSVRV DAPKHTMLIS KIKNRENKIK YVFYDPNYGM
AYFDKHSDMA AFFQKKMQQY DFPDDSVSFH PLDYSNVSDI KISGRNLNEI IDGEIPLLYK
QEGVQLEGIT PRDGIYRVPP KNTLGVQETK HYIIVNNDIY QVEWDQTNNT WRVFDPSNTN
RSRPTVPVKQ DTNGEWFKHS ETGLKGGGPI DDIRKYIARK SAIKIFNQSI NYSATKWPPE
PIDKNIHMIW IGTKNISEKN IKLSIDTAKK NPDYNTSIIY DSGISGHEGA KKFMLEKFQD
SNVNIIDFRK KSYFSQLKQE PSFAYYEQVI AENKYAQASD ILRLLVLKYE GGIYKDIDDI
QVKGFGSLTF PKGIGVMREY APEAGKATAF PNTPIAVTKN NPIINKTLDL AVSNYQRGEK
NVLKLAGPDV FTQALYQEIP GLDSKVLNAQ LYQLELAKRQ ALGVPLEKPK NFADEQLTSA
EKEKINRPYQ SIRGLSGYVE NGADHSWAVD TNIPSTSTQT STIVTPLAPK TEMLPPVPSS
STKSSTSAPV LQEKISYNLA TDIDATDYLN QLKQKTNINN KISSPAGQCE SLMKPVSDFM
RENGFTDIRY RGMFIWNNAT EQIPMNHFVV VGKKVGKDYV FDVSAHQFEN KGMPDLNGPL
ILAAEDWAKK YRGATTRKLI YYSDFKNAST ATNTYNALPR ELVLESMEGK TFITSPNWYQ
TFKRTHNIHP EVTVSDPATF SLNYSVNPTA ENLSPPPPPP IPSHGQVPKT VTPPPPPMRS
PLSLSQPLER LPANKTKPIG FNPGENKASF SKLEEAGKHY YKDDKSRQAA PVNTMSDFDN
RYLSHTTEAP APSNVAHLAP GNIYNTKVTA KGAEKPAYDI YISKDGESLI TSSSYKVDDI
TTDSKFGKPL PYSEIMFNSL KKSGVDPKNL KRSVQASIEN KVTQDVISAI GTRIQRGQVI
RVSPTENPDA FYTLLGTDNC KATLHMLNQH AEEFGHKVVT SIEFKGTGYL VMNIGTSTQT
STIVTPPPMP GTSQLVQ
Related products :
GENTAUR Belgium BVBA BE0473327336
Voortstraat 49, 1910 Kampenhout BELGIUM
Tel 0032 16 58 90 45
Fax 0032 16 50 90 45
info@gentaur.com | Gentaur | Gentaur
GENTAUR Ltd.
Unicorn House, Station Cl
Hertfordshire, Potters Bar EN6 1TL
Whetstone London N20 9BH
Tel 020 3393 8531 Fax 020 8445 9411
uk@gentaur.com | Gentaur | Gentaur
GENTAUR France SARL
9, rue Lagrange, 75005 Paris
Tel 01 43 25 01 50
Fax 01 43 25 01 60
RCS Paris B 484 237 888
SIRET 48423788800017
RIB 30004 00187 00010092253 10
BNP PARIBAS PARIS PL MAUBERT BIC BNPAFRPPPRG
IBAN FR76 3000 4001 8700 0100 9225 310
france@gentaur.com | Gentaur | Gentaur
GENTAUR GmbH
Marienbongard 20
52062 Aachen Deutschland
Support Karolina Elandt
Tel: +49 0241 40 08 90 86, +49 0241 95 78 94 78, +49 0241 40 08 90 86
Fax: (+49) 241 56 00 47 88
Logistic :0241 40 08 90 86
Bankleitzahl 39050000
IBAN lautet DE8839050000107569353
Handelsregister Aachen HR B 16058
Umsatzsteuer-Identifikationsnummer *** DE 815175831
Steuernummer 201/5961/3925
de@gentaur.com | Gentaur | Gentaur
GENTAUR U.S.A
Genprice Inc, Logistics
547, Yurok Circle
San Jose, CA 95123
CA 95123
Tel (408) 780-0908,
Fax (408) 780-0908,
sales@genprice.com
Genprice Inc, Invoices and accounting
6017 Snell Ave, Ste 357
San Jose, CA 95123
GENTAUR Nederland BV
NL850396268B01 KVK nummer 52327027
Kuiper 1
5521 DG Eersel Nederland
Tel: 0208-080893 Fax: 0497-517897
nl@gentaur.com | Gentaur | Gentaur
IBAN: NL04 RABO 0156 9854 62 SWIFT RABONL2U
GENTAUR Spain
tel:0911876558
spain@gentaur.com | Gentaur | Gentaur
ГЕНТАУЪР БЪЛГАРИЯ
ID # 201 358 931 /BULSTAT
София 1000, ул. "Граф Игнатиев" 53 вх. В, ет. 2
Tel 0035924682280 Fax 0035924808322
e-mail: Sofia@gentaur.com | Gentaur | Gentaur
IBAN: BG11FINV91501014771636
BIC: FINVBGSF
GENTAUR Poland Sp. z o.o.
ul. Grunwaldzka 88/A m.2
81-771 Sopot, Poland
TEL Gdansk 058 710 33 44 FAX 058 710 33 48
poland@gentaur.com | Gentaur | Gentaur
Other countries
Österreich +43720880899
Canada Montreal +15149077481
Ceská republika Praha +420246019719
Danmark +4569918806
Finland Helsset +358942419041
Magyarország Budapest +3619980547
Ireland Dublin+35316526556
Luxembourg+35220880274
Norge Oslo+4721031366
Sverige Stockholm+46852503438
Schweiz Züri+41435006251
US New York+17185132983
GENTAUR Italy
SRL IVA IT03841300167
Piazza Giacomo Matteotti, 6
24122 Bergamo
Tel 02 36 00 65 93
Fax 02 36 00 65 94
italia@gentaur.com | Gentaur | Gentaur
Pathways :
WP1714: Tyrosine metabolism
WP1049: G Protein Signaling Pathways
WP1165: G Protein Signaling Pathways
WP1371: G Protein Signaling Pathways
WP1438: Influenza A virus infection
WP1493: Carbon assimilation C4 pathway
WP1502: Mitochondrial biogenesis
WP1531: Vitamin D synthesis
WP1566: Citrate cycle (TCA cycle)
WP1613: 1,4-Dichlorobenzene degradation
WP1616: ABC transporters
WP1624: Bacterial secretion system
WP1625: Base excision repair
WP1644: DNA replication
WP1650: Fluorobenzoate degradation
WP1654: gamma-Hexachlorocyclohexane degradation
WP1657: Glycerolipid metabolism
WP1659: Glycine, serine and threonine metabolism
WP1661: Glyoxylate and dicarboxylate metabolism
WP1663: Homologous recombination
WP1665: Limonene and pinene degradation
WP1672: Mismatch repair
WP1673: Naphthalene and anthracene degradation
WP1675: Nitrogen metabolism
WP1676: Non-homologous end-joining
Related Genes :
Bibliography :
Enter catalog number :
Favorites Pages:
No Favorits